About Tianjin Eye Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Tianjin Eye Hospital
16
Hoffmann-La Roche
4
Allergan
2
Chengdu Kanghong Biotech Co., Ltd.
2
Bayer
1
Coopervision, Inc.
1
Menicon Co., Ltd.
1
Peking University
1
Quark Pharmaceuticals
1
Shanghai Henlius Biotech
1
SightGlass Vision, Inc.
1
Clinical Trials at Tianjin Eye Hospital
During the past decade, Tianjin Eye Hospital conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 3 clinical trials were completed, i.e. on
average, 9.4% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 3 clinical trials were completed. i.e. 21.4%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Pneumatic Retinopexy Versus Vitrectomy With Gas for Retinal Detachment Due to Myopic Macular Hole
2005-01-01
2006-12-01
Completed
231
A Safety and Efficacy Study of Dexamethasone Versus Laser Photocoagulation in Participants With Diabetic Macular Edema
2016-01-08
2019-11-01
Completed
284
Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
2016-02-24
2019-07-01
Terminated
732
Safety of GANFORT® Ophthalmic Solution in Chinese Patients With Open-angle Glaucoma or Ocular Hypertension
2015-11-10
2018-06-21
Completed
750
Multi-center Clinical Trial on Corneal Morphology Analysis in Chinese Population
2015-11-01
2019-12-01
Unknown status
50,000
Conbercept Ophthalmic Injection for Patients With Macular Edema Caused by Branch Retinal Vein Occlusion
2016-04-13
2020-10-16
Completed
255
Conbercept Ophthalmic Injection for Patients of Central Retinal Vein Occlusion
2016-05-24
2020-09-28
Completed
242
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Tianjin Eye Hospital" #1 sponsor was "Tianjin Eye Hospital" with 16 trials, followed by "Hoffmann-La Roche" with 4 trials
sponsored, "Allergan" with 2 trials sponsored, "Chengdu Kanghong Biotech Co., Ltd." with 2 trials sponsored and "Bayer"
with 2 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Tianjin Eye Hospital"
#1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator, "Alexandria University" with 1 trials as a collaborator, "Belgian Ocular Laser Centre" with 1 trials as a collaborator, "Gansu Provincial Hospital" with 1 trials as a collaborator and "Health Science Center of Xi'an Jiaotong University" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were
collaborators in the rest 16 trials.
Clinical Trials Conditions at Tianjin Eye Hospital
According to Clinical.Site data, the most researched conditions in "Tianjin Eye Hospital" are
"Myopia" (10 trials), "Macular Edema" (5 trials), "Branch Retinal Vein Occlusion" (3 trials), "Myopia, Progressive" (3 trials) and "Central Retinal Vein Occlusion" (2 trials). Many other conditions were trialed in "Tianjin Eye Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Tianjin Eye Hospital
Most popular intervention types in "Tianjin Eye Hospital" are "Drug" (14 trials), "Device" (8 trials), "Other" (8 trials) and "Procedure" (8 trials). Other intervention types were less common.
The name of intervention was led by "Aflibercept" (4 trials), "Faricimab" (4 trials), "Sham Procedure" (4 trials), "Single vision lens" (2 trials) and "+2D PDL" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Tianjin Eye Hospital
The vast majority of trials in "Tianjin Eye Hospital" are
33 trials for "All" genders.
Clinical Trials Status at Tianjin Eye Hospital
Currently, there are NaN active trials in "Tianjin Eye Hospital".
undefined are not yet recruiting,
8 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 16 completed trials in Tianjin Eye Hospital,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Tianjin Eye Hospital, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 10 trials that are defined as “Not Applicable".